ASGCT 2026

CONFERENCE

ASGCT 2026

Cyagen will attend ASGCT 2026 on May 11–15 in Boston, MA. Our experts will be available to discuss advanced techniques on antibody, drug development strategies and showcase Cyagen’s advanced mouse models and integrated preclinical research solutions. We look forward to connecting with you!

DATE

09:00-18:30, May 11-15, 2026 EDT

LOCATION

Booth 1512, Thomas Michael Menino Convention & Exhibition Center

Accelerate Your Pipeline with Cyagen's Models & CRO Expertise：From Target Validation to Proof-of-Concept

Cyagen provides high-quality models and reliable tools, scalable platforms, and expert scientific support to help accelerate translation and advance biomedical research—because at our core, we help you discover life.

Next-generation human ortholog models (HUGO-GT™): Leverage our proprietary Humanized Genomic Ortholog for Gene Therapy platform to study human-specific biology and disease mechanisms in vivo, supporting more translatable target and modality evaluation and helping reduce program risk.

CRO services for preclinical studies: Integrate model selection and in vivo study execution through Cyagen’s CRO capabilities, helping move from target validation to in vivo proof-of-concept more efficiently

AI-assisted design & development workflows: Apply AI-supported workflows across model and study design to improve experimental consistency and accelerate decision-making.

Ready-to-use rodent models: Access a broad portfolio of validated mouse strains over 18,000+ —including knockout, knockin, conditional, and humanized models—spanning multiple research areas to accelerate discovery timelines.

Viral vector packaging: Produce research-grade viral vectors—including AAV, lentivirus, and adenovirus—with a streamlined workflow to support gene delivery, functional studies, and translational research.

Custom Cell Line Model Generation: Generate custom knockout/knockin/precision-edited cell lines and provide iPSC services to support mechanistic studies, screening, and downstream validation.

Featured Experts

Resources

Swags & Offers

Featured Experts

Matthew Wheeler, Ph.D.

Vice President of Business Development and Strategy

Matthew joined Cyagen as Vice President of Business Development and Strategy bringing extensive experience in driving growth, building strategic partnerships, and leading high-performing teams in the advanced therapies sector.

Matthew holds a PhD in Biochemistry from Imperial College London and was a Group Leader at the Max-Planck Institute for Heart and Lung Research. Matthew's passion lies at the intersection of science and business, enabling innovative life science companies to accelerate growth, attract investment, and deliver transformative therapies to patients.

Mark Loetzerich, Ph.D.

Director of Business Development

Mark Loetzerich earned his PhD in molecular virology from the Ludwig Maximilian University Munich in Germany. With almost 20 years of work experience, he is an expert in the fields of both RNA- and DNA viruses & immunology. In Switzerland Mark worked at 3V Biosciences and specialized on virus-host interactions, cell death, and immune evasion mechanisms of respiratory viruses and possible countermeasures.

In the USA Mark lead a highly translational research project at the Hussman Institute in Baltimore linked to viral triggers of multiple sclerosis. Prior joining Cyagen he worked as director for infectious disease for the gene therapy program of UPenn in Philadelphia on a new biologic platform for the treatment of COVID-19 and to transfer this technology to other pandemic viral threads. Mark obtained a post-baccalaureate certificate in biochemical regulatory engineering from the UMBC and was decorated with the Hussman Meritorious Award.

Ivan Gladwyn-Ng, Ph.D.

Senior Business Development Scientist

Ivan is an accomplished scientific leader with extensive experience at the intersection of biomedical research and commercial innovation. He holds a PhD from Monash University's Australian Regenerative Medicine Institute, following a First-Class Honours degree in Medical Bioscience.

With a career spanning Europe and Asia, Ivan has led international teams, developed new business territories, and built partnerships with CRO and pharmaceutical organisations. His combination of scientific expertise and commercial strategy will support Cyagen's continued expansion and success across global markets.

Spotlight Presentation

Accelerate Interdisciplinary Discovery: Leveraging Cyagen's Innovative Mouse Models for Translational Research

Resources

View

Swags & Offers

Visit us and unlock exclusive event swags and limited-time offers!

Swag Bag Extravaganza

Make your visit to an unforgettable experience! Grab your Cyagen swag bag filled with goodies that every researcher loves. Don’t miss out on our:

Data Cables

Notebook

Sticker Notes

Sticker

Stuffed Toy

Tote Bag

Unlock Your Event-Exclusive Savings!

Let’s talk biotech innovation — from custom model generation to scalable CRO workflows. Visit us to enjoy event-only pricing on gene editing, iPSC, and vector services.

Connect with Us About This Event

Interested in this event's insights or materials? Submit your information below and we will get back to you.

Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:

Yes, I want to receive updates on products, services, and events from Cyagen.

You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.

By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.